OSGEP: A Potential Drug Target and Biomarker for Threonylcarbamoyladenosine Synthesis

Target Name: OSGEP

NCBI ID: G55644

OSGEP

OSGEP: A Potential Drug Target and Biomarker for Threonylcarbamoyladenosine Synthesis

OSGEP (Oxidative Stress-Grown Enzyme-P producing) is a protein that plays a crucial role in threonylcarbamoyladenosine (TCA) biosynthesis, which is a key step in the synthesis of adenosine, a potent immunosuppressive agent. TCA is widely used in cancer treatment as a derived metabolite. However, its use can lead to oxidative stress, which can exacerbate tissue damage and contribute to the development of cancer. The regulation of TCA biosynthesis is crucial to maintain cellular homeostasis and prevent oxidative stress.

OSGEP: Structure and Function

The structure of OSGEP is important in understanding its function. The protein consists of 254 amino acids with a calculated molecular mass of 31 kDa. It has a catalytic active site, a transmembrane region, and a cytoplasmic region. The catalytic active site is the site of the enzyme's catalytic activity, where the substrate binds and the product is generated. The transmembrane region is responsible for the transport of the enzyme from the cytoplasm to the cell surface, where it can interact with its substrate. The cytoplasmic region interacts with the cell surface and may participate in the regulation of the enzyme's activity.

The function of OSGEP is to catalyze the conversion of TCA to TCA-S, which is a key step in the biosynthesis of adenosine. TCA-S is a stable metabolite that can be easily detected in cell culture supernatants. The conversion of TCA to TCA-S is a critical event in the regulation of cellular homeostasis, as TCA has immunosuppressive properties and can contribute to the development of cancer.

OSGEP is a member of the superfamily of enzymes known as thioredoxins, which are involved in the regulation of cellular homeostasis and redox reactions. The thioredoxin family includes several well-known enzymes, such as thioredoxin-1, thioredoxin-2, and thioredoxin-3, which are involved in various cellular processes, including DNA repair, metabolism, and stress response. OSGEP shares structural features with these other thioredoxins, including a catalytic active site, a transmembrane region, and a cytoplasmic region.

Drug Targeting and Biomarker

The potential drug targeting of OSGEP is its role in TCA biosynthesis, which is a key step in the synthesis of adenosine. Adenosine has been shown to have immunosuppressive properties and can contribute to the development of cancer. The regulation of TCA biosynthesis is crucial to maintain cellular homeostasis and prevent oxidative stress, which can exacerbate tissue damage and contribute to the development of cancer.

OSGEP can be potentialized as a drug target by inhibiting its catalytic activity. This would result in a decrease in TCA biosynthesis and a reduction in the production of adenosine. By inhibiting OSGEP, a drug could be developed that targets the regulation of TCA biosynthesis and has potential anti-inflammatory and immunosuppressive effects.

OSGEP can also be used as a biomarker for monitoring the efficacy of cancer treatments that target TCA biosynthesis. The levels of TCA in cell culture supernatants can be used as a marker for the efficacy of anti-inflammatory and immunosuppressive treatments. By measuring the levels of TCA in cell culture supernatants, researchers can monitor the response of cancer cells to different treatments and determine their efficacy.

Conclusion

In conclusion, OSGEP is a protein that plays a crucial role in the biosynthesis of adenosine, which can contribute to the development

Protein Name: O-sialoglycoprotein Endopeptidase

Functions: Component of the EKC/KEOPS complex that is required for the formation of a threonylcarbamoyl group on adenosine at position 37 (t(6)A37) in tRNAs that read codons beginning with adenine. The complex is probably involved in the transfer of the threonylcarbamoyl moiety of threonylcarbamoyl-AMP (TC-AMP) to the N6 group of A37. OSGEP likely plays a direct catalytic role in this reaction, but requires other protein(s) of the complex to fulfill this activity

The "OSGEP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OSGEP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets